Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
CLDI holding history
Calidi Biotherapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CLDI overviewAll 13F holders of CLDIFull Q4 2025 holdings
- Shares (Q4 2025)
- 34,728
- Value
- $40.6K
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 34,728 | $40.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 34,728 | $52.8K | <0.1% | +5,280+17.9% | AddedConverted for a 1-for-12 split | Holders |
| Q2 2025 | 353,380 | $81.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 353,380 | $200.0K | <0.1% | +292,006+475.8% | Added | Holders |
| Q4 2024 | 61,374 | $70.6K | <0.1% | +61,374 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −1,494−100.0% | Sold outConverted for a 1-for-10 split | Holders |
| Q2 2024 | 14,939 | $2.99K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 14,939 | $8.44K | <0.1% | +2,491+20.0% | Added | Holders |
| Q4 2023 | 12,448 | $18.8K | <0.1% | +12,448 | New | Holders |